none
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) an employee of the National Cancer Center 2) Subjects who have given written consent for this study 3) The subject is scheduled to receive the COVID19 or is within 12 months of receiving the second (or last) dose of the vaccine.
Exclusion criteria
Exclusion criteria: Subjects who are determined not to be appropriate subjects for this study by the Principal Investigator or the Research Office
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SARS-CoV-2 antibody positivity after 2 doses of vaccine | — |
Countries
Japan
Contacts
National Cancer Center Hospital Department of experimental development